Mutations in RHBDF2 accelerate tumorigenesis by activating epidermal growth factor receptor (EGFR) signaling (Hosur et al., 2014) and are associated with tylosis esophageal cancer (Blaydon et al., 2012). The gene discussed is EGFR; the disease is Non-epidermolytic palmoplantar keratoderma.